EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 8-Jul-2025 13:10 ET (8-Jul-2025 17:10 GMT/UTC)

13-Feb-2025

Project Cure CRC ignites innovation in 2025 with $10.5 million in research, K-SPY debut & renewed RFP

Colorectal Cancer Alliance
Grant and Award Announcement

The leading nonprofit Colorectal Cancer Alliance (Alliance) is making bold strides in its mission to put an end to the disease. Its Project Cure CRC research initiative awarded new grants, convened top scientists to spark breakthrough advancements at its Cure CRC Summit, and unveiled K-SPY, a groundbreaking multi-center platform trial for high-risk colorectal cancer cases. Since its launch, Project Cure CRC has received 275 proposals, of which 22 have been approved totaling $10.5 million in awards. The latest awards reflect $2.8 million of the overall funding for urgently needed innovations. With significantly more funds available, the Alliance issues a renewed Project Cure CRC Request for Proposals from researchers with cutting-edge colorectal cancer studies.

13-Feb-2025

MSK Research Highlights, February 13, 2025

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

New research from Memorial Sloan Kettering Cancer Center (MSK) supported the approval of a new treatment for ER-positive, HER2-negative advanced breast cancer; suggests a new strategy for overcoming resistance to Akt inhibitors in patients with PTEN-mutated prostate cancers; provides new understanding of B cell lymphomas that could lead to new treatments; examines using ChatGPT to help capture patient-reported outcomes; and developed the first customizable, scalable model for palliative care training for emergency departments.

13-Feb-2025

Critical gaps in research hinder breast cancer screening for Black women

University of Surrey
Peer-Reviewed Publication

Black women in the UK face a disproportionately higher risk of dying from breast cancer, often diagnosed at later stages with more aggressive forms of the disease. This disparity is compounded by significantly lower rates of breast cancer screening among Black women compared to other groups.

Journal: Psycho-Oncology

13-Feb-2025

Guardian molecule keeps cells on track – new perspectives for the treatment of liver cancer

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Peer-Reviewed Publication

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational Brain Research (HITBR), and from the European Molecular Biology Laboratory (EMBL). The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a fundamental principle of carcinogenesis for several years. The Heidelberg researchers were able to show that the newly discovered sentinel is so powerful that it can slow down highly potent cancer drivers and cause malignant liver tumors to regress in mice.

Journal: Nature Genetics

12-Feb-2025

Bringing cancer care closer to home: Federal program expands treatment to rural and frontier communities

Huntsman Cancer Institute
Grant and Award Announcement

The federally funded program aims to improve cancer care for rural and frontier residents in the Mountain West, bringing the latest in cancer care by providing access to clinical trials.

12-Feb-2025

Vitamin E succinate controls tumor growth and enhances immunotherapy effects

University of Chicago Medical Center
Peer-Reviewed Publication

High levels of fat mass and obesity-associated protein (FTO) have been linked to tumor growth and resistance to immunotherapy. Researchers identified vitamin E succinate as an effective agent in controlling tumor growth by promoting the degradation of FTO.

Journal: Proceedings of the National Academy of Sciences

12-Feb-2025

New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy

Oregon Health & Science University
Peer-Reviewed Publication

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

Journal: Science Translational Medicine

12-Feb-2025

MAGE-4 promotes tumor progression by halting antitumor responses

Baylor College of Medicine
Peer-Reviewed Publication

A new study by researchers at Baylor College of Medicine and collaborating institutions reveals a novel strategy that allows tumors to evade the body’s immune response critical for their elimination.

Journal: Science Advances

12-Feb-2025

Dana-Farber researchers to present key transplant and cellular therapy studies at 2025 tandem meetings

Dana-Farber Cancer Institute
Business Announcement

Dana-Farber Cancer Institute researchers will present key research studies at the 2025 Tandem Meetings, the premier conference in hematopoietic cell transplantation (HCT) and cellular therapy. Organized by the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood and Marrow Transplant Research (CIBMTR), the event will take place February 12–15 in Honolulu, Hawaii.

12-Feb-2025

Long-term yogurt consumption tied to decreased incidence of certain types of colorectal cancer

Mass General Brigham
Peer-Reviewed Publication

KEY TAKEAWAYS

Mass General Brigham researchers looked at the role of long-term diet and the gut bacteria in colorectal cancer using data on participants who had been followed for three decades.

They found that people who consumed two or more servings of yogurt per week tended to have lower rates of colorectal cancer positive for Bifidobacterium.

The findings suggest that yogurt consumption may change the microbiome, leading to a protective effect for some types of colorectal cancer.

Journal: Gut Microbes
Funder: NIH/National Institutes of Health, Project P Fund, Cancer Research UK, Prevent Cancer Foundation, Brigham and Women's Hospital, American Institute for Cancer Research, American Cancer Society, Cancer Research UK, NIH/National Cancer Institute, Bowelbabe Fund for Cancer Research UK, Institut National Du Cancer